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Abstract: - PURPOSE: Since about ten years a new modality for whole body hyperthermia, a compact and user-
friendly infrared (IR) 'sauna' has become available. Patients with musculoskeletal disorders report positive effects.
RELEVANCE: Until now hardly any research was done in this field. Therefore in this study the short-term
physiological and clinical effects in healthy subjects and patients with Rheumatoid Arthritis (RA) and
Ankylosing Spondylitis (AS) were investigated. SUBJECTS: 17 RA patients (3 male, 14 female), 19 AS patients
(12 male, 7 female) and 21 healthy subjects (11 male, 10 female) with a mean age (sd) of 47 (13), 45 (10) and 45
(7) years respectively were included in the study. METHODS AND MATERIALS: Patients with RA or AS and
healthy subjects were treated with whole-body hyperthermia by means of a 30 minutes stay in a IR sauna cabin at
an adjusted temperature of 55°C. Before and directly after the sauna treatment in both RA and AS patient groups
pain and stiffness and were measured on a 10 centimetres Visual Analogue Scale. Besides that in all groups body
weight was measured before and after treatment. Additionally during the treatment heart rate, systolic and
diastolic blood pressure, skin surface and core temperature were continuously monitored. Also general well-
being during and after treatment was investigated. RESULTS: Pain and stiffness improved significantly during
treatment; mean between 40% and 60%. The mean weight loss during treatment due to transpiration was
significant (p<0.001) in all groups, but it was significantly higher (p<0.001) in healthy subjects (-0.5 kg) than in
patients (both RA and AS -0.3 kg). During treatment mean heart rate, skin and core temperature increased
significantly p<,0.001) in all groups, while blood pressures showed small but significant declines. No significant
differences between groups were observed. On average all subjects felt comfortable during and especially after
treatment. CONCLUSION: Infra red whole body hyperthermia has statistically significant positive direct effects
upon pain and stiffness in RA as well as in AS patients. Looking at the physiological effects, RA and AS patients
do not respond differently from age and gender matched healthy controls.
Key-Words: physiology, physiotherapy, infrared hyperthermia, rheumatoid arthritis, ankylosing spondylitis, healthy
subjects
1 Introduction
Heat treatment in patients with rheumatic disorders is
a well-accepted form of physiotherapy treatment.
Through the ages it has been widely used. Initially
the basis for local application of heat was largely
empirical. In the last few decades more evidence for
its beneficial effects has been obtained from clinical
research [1,2]. Pain and stiffness diminish and grip
strength and joint function (range of motion) improve
after local heat therapy [3]. Although beneficial
effects of total body hyperthermia have been reported
[4], the methodological quality of the studies is poor
[5] and the use of this therapy is not widely spread
over Western Europe. Results from studies
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concerning Finnish saunas showed good clinical
effects for rheumatic and musculoskeletal disorders
[6-8]. For a few years a compact and user friendly
infrared 'sauna' has become available in the
Netherlands. Patients reports and clinical experience
appeared to be promising and a recent study showed
short-term improvement of pain and stiffness,
including a trend towards long-term beneficial effects
in Rheumatoid Arthritis (RA) and Ankylosing
Spondylitis (AS) [9]. The infrared sauna has the
heating effect of a high ambient temperature, like a
traditional Finnish sauna, but also due to the physical
properties of infrared, some radiant heat penetrates,
depending on the wave length, maximally up to 4
mm. into the superficial skin. This may result in
different physiological responses compared to the
Finnish sauna. For that reason we previously
investigated the physiological effects of infrared
whole body hyperthermia in young healthy subjects
[10]. Fifteen healthy subjects were exposed to heat
treatment in an infrared cabin at three different
intensities (40C, 55C and 70C). Mean skin surface
temperature, core temperature and heart rate
increased significantly. Significant loss of
bodyweight after treatment was also found. In
general a small decrease of systolic and diastolic
blood pressure was shown. According to the majority
of the subjects the treatment at 70C was too intense
and considered as uncomfortable towards the end of
the 30 minutes session. The 55C mode was well
tolerated, but the treatment intensity at 40C was
unsatisfactory. So from that moment the intensity for
clinical treatment of rheumatic diseases was chosen
at 55C. Despite the fact that no physiological
problems in young healthy subject were encountered,
the issue still is how rheumatic patients physically
cope with such an intense heat stress. Nevertheless
they are dealing with a chronic and systemic
inflammatory disease that may be negatively
influenced by IR heat. Therefore the purpose of this
study is to investigate the influence of whole body IR
hyperthermia upon superficial skin temperature, core
temperature, heart rate, blood pressure, body weight,
wellbeing, perceived pain and stiffness.
2 Patients, subjects and methods
Patients were recruited consecutively from the
rheumatology out-patients clinic (JJR) in the
general district hospital Medisch Spectrum Twente
in Enschede, the Netherlands. All healthy volunteers
were employees from the same hospital.
2.1 Inclusion criteria
People with Rheumatoid Arthritis (RA) according
to the revised ARA [11] or with Ankylosing
Spondylitis (AS) according to the New York [12]
criteria and between 18 and 70 years of age were
included. Only patients with chronic disease that
had been stable during at least 3 months without
change of medications were allow to participate.
2.2 Exclusion criteria
Patients with signs of acute inflammatory activity as
judged by the consulting rheumatologist were
excluded; if morning stiffness lasted longer than 1
hour or when more than three joints were actively
inflamed. Patients with inflammation activity were
not included because heat treatment may aggravate
clinical signs in an acute phase of the disease.
Patients were excluded who were permanently
wheelchair bound or bed ridden. Those with the
following co-morbidities were also excluded: heart
disease, skin disease, malignancy, asthmatic
bronchitis or psychiatric disorders. Healthy subjects
who had a history of systemic disease and had been
treated by a general practitioner or a hospital
consultant for any gastro-intestinal, cardio-vascular
or respiratory symptoms during the previous year
were excluded.
2.3 Approval
All subjects and patients had previous experiences
with traditional Finnish sauna, but not with infrared
sauna. After oral and written information about the
study and the possible clinical effects and side
effects of IR whole body hyperthermia, patients
were invited to participate. Informed consent was
obtained from all patients and subjects, according
to the Declaration of Helsinki. The hospitals ethics
committee approved the study design.
2.4 Treatment
The subjects were treated in the Health Company
Infrared Cabin (The Health Company, PO Box 321,
2400 AH Alphen a/d Rijn, the Netherlands), which
was 130 cm x 90 cm x 190 cm in size. The
temperature in the cabin can be adjusted from normal
ambient room temperature up to 90C. The subjects
were seated in the infrared cabin, which has 6 heating
sources; 3 at the back, 2 in front besides the entrance
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and 1 under the bench behind the lower legs of the
subjects. The infrared used in this study had an ultra
long wavelength between 5.000 nm and 1.000.000
nm. All treatments were given between 1 and 6 pm.
During one single session, the subjects were treated
in the infrared cabin for 30 minutes at an adjusted
temperature of 55C. According to the manufacturers
recommendation a pre-heating time of 15 minutes
was used. Before the session, the subjects sat in
bathrobe next to the cabin to relax for 15 minutes.
Their left knee was not covered with the bathrobe but
was exposed to the environment (mean ambient
temperature outside the cabin during the study was
22C). This was done to create comparable baseline
values because during treatment, skin temperature
was recorded over the knee joint. During the 30
minutes of infrared treatment the subject sat naked on
the bench in the middle of the infrared cabin and no
drinks were provided during that time. Leaning
against the wall of the cabin was not allowed.
2.5 Measurements
Before, during and after this single treatment session,
several measurements were taken to monitor the
subject’s physiological condition.
2.5.1 Skin and core temperature
The skin surface temperature was measured on the
left knee using a flexible Exacon S-01 (Polystan
Benelux, De Steiger 172, Almere-Haven, The
Netherlands) probe. The tip of the probe was placed
over the joint line between the medial femoral
condyle and the medial aspect of the tibial plateau.
The measuring tip of the probe was protected from
direct influence of the infrared radiation by a 0.3 cm-
thick felt layer and fixed to the skin with tape. The
possibility of temperature conduction through the
probe to the measuring tip was investigated. Heat
application to the wire of the probe did not change
the temperature as measured at the tip, indicating
good isolation of the probe [13].
A flexible Ellab rectal probe (Lameris Medical
Equipment, Groenekanseweg 10 3737 AG
Groenekan, the Netherlands), covered with a plastic
coating, was used to measure core temperature. The
subjects were instructed to insert the probe by
themselves.
Both probes were introduced into the infrared cabin
through a small hole (diameter 2 cm.) in the window
and connected to an Exacon MC 9200 medical
thermometer with a measuring range of -80C to
120C and an accuracy of ± 0.1C. The Exacon
thermometer was connected to an Exacon RC-2120
recorder for continuous recording of the skin surface
and core temperature for at least 30 minutes of
treatment.
2.5.2 Blood pressure and heart rate
A Dynamap CCU (Portanje, Kabelweg 44, 1014 BB
Amsterdam, the Netherlands) was used to measure
systolic and diastolic blood pressure and for
measuring heart rate. The cuff of the Dynamap was
wrapped around the left upper arm of the subjects
and measurements were taken every 5 minutes
directly before, during and up to end of treatment.
2.5.3 Body weight
Before and after infrared treatment every subject was
weighed naked on a SECA 711 Mechanical Column
Scale (SECA gmbh & Co, Hammer Steindamm 9-25,
22089 Hamburg, Germany)
2.5.4 Wellbeing
The subjects scored their well being on a 5-point
ordinal Likert scale (1 = very uncomfortable, 2 =
uncomfortable, 3 = neutral, 4 = comfortable, 5 = very
comfortable). This measurement was taken 15 and 30
minutes after the start of the treatment, when they
were still in the infrared cabin and 30 minutes
afterwards.
2.5.5 Pain and stiffness perception
Besides these physiological measurements the AS
and RA patients were asked to score their perceptions
of pain[14] and stiffness[15] just before and after
treatment on a 100 millimeters Visual Analogue
Scale.
2.6 Statistical analysis.
Normally distributed continues data were expressed
as means with standard deviations or 95% confidence
intervals. This was done with the descriptive
statistics explore command in SPSS 17.0 [16] by
making histograms, scatter graphs, normality plots,
normal curves and carrying out normality tests
(Kolmogorov–Smirnov and Shapiro–Wilk). The
median was additionally used for presenting central
tendency in not normally distributed data. Nominal
and ordinal data are presented in frequency tables.
Differences within and between groups were
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Table 1: Patients’ characteristics
RA patients AS patients Healthy subjects
Gender 3 male, 14 female 12 male, 7 female 11 male, 10 female
Age 47 sd 13 (26-70) 45 sd 10 (23-58) 45 sd 7 (39-55)
Disease duration 13 sd 10 (3 – 29) 21 sd 10 (4 – 40)
Mean in years; Standard Deviation (Minimum – Maximum); RA rheumatoid arthritis, AS ankylosing spondylitis.
Table 2: Summary of effects on physiological variables
RA patients AS patients Healthy subjects
Heart rate (beats/min)
Treatment begin
Treatment end
difference
87 (79 – 95)
115 (106 – 124)
28 (20 – 35) **
82 (75 – 89)
112 (104 – 120)
30 (24 – 36) **
82 (75 – 89)
110 (102 – 118)
28 (21 – 35) **
Skin temperature (C)
Treatment begin
Treatment end
difference
32.1 (31.4 – 32.8)
38.1 (37.7 – 38.4)
6.0 (5.2 – 6.8) **
32.6 (31.9 – 33.3)
37.9 (37.5 – 38.2)
5.3 (4.7 – 5.9) **
33.0 (32.4 – 33.7)
38.6 (38.2 – 38.9)
5.5 (5.1 – 6.0) **
Core temperature (C)
Treatment begin
Treatment end
difference
37.4 (37.2 -37.7)
37.8 (37.6 – 38.0)
0.4 ( 0.3 – 0.5) **
37.1 (36.9 – 37-4)
37.6 (37.4 – 37.8)
0.4 (0.3 – 0.5) **
37.0 (36.8 – 37.2)
37.8 (37.6 – 37.9)
0.7 (0.5 – 0.9) **
Systolic Blood pressure
(mmHg)
Treatment begin
Treatment end
difference
131 (124 – 139)
119 (111 – 127)
-12 (-22 - -1) *
134 (127 -141)
119 (112 – 127)
-14 (-21 - -8) **
130 (124 – 137)
125 (118 – 132)
-5 (-12 – 5)
Diastolic Blood pressure
(mmHg)
Treatment begin
Treatment end
difference
78 (72 – 85)
67 (62 – 73)
-11 (-21 – 0) *
81 (74 – 87)
66 (60 – 71)
-15 (-22 - -7) **
80 (75 – 86)
72 (66 -77)
-9 (-14 - -4) **
Body weight (kg)
Treatment begin
Treatment end
difference
76.6 (68.5 – 84.7)
76.3 (68.2 – 84.4)
-0.3 (-0.4 - -0.2) **
76.6 (72.0 – 81.2)
76.4 (71.7 – 80.9)
-0.3 (-0.3 – 0.2) **
72.6 (68.8 – 76.8)
72.1 (68.1 – 76.1
- 0.5 (-0.6 - -0.5) **
Mean (95% CI); RA rheumatoid arthritis, AS ankylosing spondylitis.
* p<0.05, ** p<0.001.
respectively analysed by means of repeated
measures analysis with Bonferroni correction. For
non-parametric data (Wellbeing on an ordinal
Likert scale) within groups Wilcoxon Signed Rank
Test for related samples was applied. For
comparison between groups the Kruskal Wallis test
was applied. Level of significance (α) was chosen
at 0.05. All Statistical calculations were done using
SPSS 17.0 for Windows.
3 Results
All invited patients agreed to cooperate in the
study, only one AS patient could not participate due
to non medical reasons.
In total 57 subjects took part in the study; 17 RA
patients, 19 AS patients and 21 healthy volunteers.
Subject’s characteristics age, gender and disease
duration are summarized in table 1. No statistically
significant differences were found between
subgroups.
Table 2 shows the changes in heart frequency, skin
surface and core temperature, and blood pressure.
Comparing the start to the end of the treatment, mean
heart rate and skin and core temperature increased
statistically significant (p<0.001) within groups. Both
mean systolic and diastolic blood pressure decreased
statistically significant (p<0.05 or p<0.001) within all
groups. Only the decrease in systolic blood pressure
in the healthy subjects group was not statistically
significant (p=0.12). Between groups no statistically
significant differences were found (Table 2). The
similarities between groups is illustrated in figures 1-
5.
All three groups demonstrated a small but statistically
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significant (p<0.001) decrease in mean bodyweight
following treatment (Table 2). The healthy subject
lost statistically significant (p<0.001) more weight
than RA and AS patients.
All subjects felt comfortable during and after the
treatment session. Especially after treatment, 84.2%
to 88.5% in each group felt comfortable or even
very comfortable (Table 3). There was no
statistically significant difference in wellbeing as
measured between the two first instances (during
treatment), although the AS patients felt less
comfortable towards the end of treatment, but a half
an hour after they almost all felt (very) comfortable
(Table 3). The perceived wellbeing 30 minutes
after treatment in all groups showed better
statistically significance compared to the other two
measurement points (p<0.01). Between groups no
statistically significant differences were detected.
The improvement of pain and stiffness in RA and
AS patients during an infrared session was
clinically relevant and also statistically significant
(Table 4).
4 Conclusion
Patients with non-acute Ankylosing Spondylitis and
Rheumatoid Arthritis respond to IR whole body
hypertermia in the same way as healthy subjects with
comparable age. Despite their stable inflammatory
disease, physiological reactions to heat stress do not
differ from healthy persons. From that point of view
there are no contraindications for IR whole body
hyperthermia. Besides that, clear clinically beneficial
direct effects upon pain and stiffness were observed.
So immediate symptomatic relief, without
aggravation of inflammatory disease activity seems to
be feasible.
5 Discussion
Large increases in skin surface temperature were
found during treatment (mean changes from 5.3C to
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Table 3: Wellbeing during and after IR sauna
RA patients After 15 minutes After 30 minutes 30 minutes after treatment
n* % n* % n* %
1 0 0 2 11.8 0 0
2 2 11.8 2 11.8 0 0
3 3 17.6 2 11.8 2 11.8
4 10 58.8 9 52.9 10 58.8
5 2 11.8 2 11.8 5 29.4
AS patients
1 0 0 3 15.8 0 0
2 4 21.1 4 21.1 1 5.3
3 3 15.8 4 21.1 2 10.5
4 10 52.6 2 10.5 10 52.6
5 2 10.5 6 31.6 6 31.6
Healthy
Subjects
1 0 0 0 0 0 0
2 0 0 3 14.3 0 0
3 6 28.6 7 33.3 3 14.3
4 12 57.1 7 33.3 9 42.9
5 3 14.3 4 19.0 9 42.9
* Number of patients; 1 = very uncomfortable, 2 = uncomfortable, 3 = neutral, 4 = comfortable, 5 = very comfortable,
RA rheumatoid arthritis, AS ankylosing spondylitis
Table 4: Immediate clinical effects
Pain Stiffness
Before After Before After
RA patients 25 (13 - 36)
20
15 (6 - 25)
10*
25 (15 - 36)
31
12 (6 - 18)
12*
AS patients 26 (18 - 34)
28
14 (6 - 22)
7*
41 (29 – 53)
38
17 (8 - 26)
6**
VAS, 0-100 mm; Mean (95%CI) and Median; * p < 0.01; ** p < 0.001, RA rheumatoid arthritis, AS ankylosing
spondylitis.
6.0C). However the mean core temperature
increased only slightly (0.3C tot 0.5C) but
significantly. To our knowledge no previous studies
concerning infrared whole body hyperthermia
treatment were performed. Although not quite
comparable, studies in healthy subjects investigating
the effect of Finnish dry heat sauna showed mean
core temperature increases of 0.8C to 2.9C [17-20].
The differences between these results and those from
our study can be explained by the relatively lower
cabin temperature during infrared treatment. In most
of these studies the core temperature was not
measured rectally, but the sublingual or oral
temperature was chosen as an estimate for the core
temperature, which may have influenced results.
It appears that the human physiological temperature-
regulation system in healthy subjects as well as in
rheumatic patients is capable of maintaining the core
temperature at values between 37C and 38C,
despite moderate to severe ambient temperature
increases and radiant heat from the infrared devices.
In order to achieve this homeostasis, physiological
mechanisms such as increased perspiration and
vasodilatation of superficial skin vessels occur. These
phenomena were also found in our study. Subjects
lost between 0.3 and 0.5 kg of bodyweight during
treatment, probably due to the increased perspiration.
In a previous study we found significant correlations
of -0.51 (p=0.05), -0.58 (p=0.04) and -0.91 (p=0.01)
respectively at increasing cabin temperature
intensities, between the loss of bodyweight on one
hand and the increase of relative humidity during
treatment on the other hand [10].
Due to the vasodilatation of superficial vessels, a
decrease in blood pressure can be expected. To
compensate for these lower values predominantly the
ADVANCES IN BIOMEDICAL RESEARCH
ISSN: 1790-5125 257 ISBN: 978-960-474-164-9
heart rate and the cardiac output are increased. As
mentioned in our study only small and irregular
decreases of blood pressure were found and the heart
rate increased clearly (Table 2, Fig. 1, 4 and 5). In
previous studies dealing with the effects of Finnish
sauna [18-20] there have been similar findings of an
average increase in heart rate and a slight decrease in
diastolic blood pressure. From the literature [18-20]
hardly any changes in systolic blood pressure were
found during sauna treatment, however our subjects
showed a decrease in systolic blood pressure. A
reasonable explanation for this discrepancy is not
available at this moment.
As far as we know from literature searches in
Medline, Embase, Cinahl, EBSCOhost, Cochrane
library, in the database of the documentation centre
from the Dutch National Institute for Allied Health
Care and from an extensive hand search, our study is
the first to investigate the physiological effects of
infrared whole body hyperthermia in patients and
comparable healthy controls. Although people with
rheumatic diseases or disorders of the
musculoskeletal system have reported infrared whole
body hyperthermia treatment to be beneficial and
some immediate effects are relatively proven, further
research is necessary. Especially controlled
longitudinal studies investigating the long term
outcome and possible side effects are warranted.
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